Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - pilocarpine hydrochloride 10 mg/ml - eye drops, solution - 1 % - pilocarpine hydrochloride 10 mg/ml - pilocarpine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

novartis pharma sa-nv - pilocarpine hydrochloride 30 mg/ml - eye drops, solution - 3 % - pilocarpine hydrochloride 30 mg/ml - pilocarpine

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 10 mg in 1 ml - isopto® carpine is indicated for the:         none. pregnancy. category c. animal reproduction studies have not been conducted with pilocarpine hydrochloride. it is also not known whether pilocarpine hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. isopto® carpine should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when isopto® carpine is administered to a nursing woman. safety and effectiveness of pilocarpine hydrochloride ophthalmic solution in pediatric patients have been established. no overall differences in safety or effectiveness have been observed between elderly and younger patients.

United States - English - NLM (National Library of Medicine)

aurobindo pharma limited - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - indications and usage pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome.

United States - English - NLM (National Library of Medicine)

northstar rx llc - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - indications and usage pilocarpine hydrochloride tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren's syndrome.

United States - English - NLM (National Library of Medicine)

eisai inc. - pilocarpine hydrochloride (unii: 0ww6d218xj) (pilocarpine - unii:01mi4q9di3) - pilocarpine hydrochloride 5 mg - salagen® tablets are indicated for 1) the treatment of symptoms of dry mouth from salivary gland hypofunction caused by radiotherapy for cancer of the head and neck; and 2) the treatment of symptoms of dry mouth in patients with sjogren’s syndrome. salagen® tablets are contraindicated in patients with uncontrolled asthma, known hypersensitivity to pilocarpine, and when miosis is undesirable, e.g., in acute iritis and in narrow-angle (angle closure) glaucoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch health ireland limited - pilocarpine nitrate - eye drops, solution - 2.0 percent weight/volume - parasympathomimetics; pilocarpine

Ireland - English - HPRA (Health Products Regulatory Authority)

bausch + lomb ireland limited - pilocarpine nitrate - eye drops, solution - parasympathomimetics; pilocarpine

Canada - English - Health Canada

jamp pharma corporation - pilocarpine hydrochloride - tablet - 5mg - pilocarpine hydrochloride 5mg - parasympathomemetic (cholinergic) agents

Australia - English - Department of Health (Therapeutic Goods Administration)

bausch & lomb australia pty ltd - pilocarpine nitrate, quantity: 20 mg/ml - eye drops, solution - excipient ingredients: purified water - chronic non-congestive glaucoma and as a miotic for reversing the action of the weaker mydriatics.